Patients Before Monopolies Act to End Conflicts of Interest Between Pharmacies, PBMs
Drug Topics
DECEMBER 13, 2024
US Senators introduced the bipartisan bill addressing pharmacy benefit managers and their affiliated pharmacies.
Fri.Dec 13, 2024
181 
Five Lessons Learned About Antimicrobial Stewardship Metrics
IDStewardship
DECEMBER 13, 2024
In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. Antimicrobial stewardship metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the safe and appropriateuse of antibiotics.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
SABCS 2024: Camizestrant Shows Promise in Combination with Ribociclib for Advanced Breast Cancer
Pharmacy Times
DECEMBER 13, 2024
The novel camizestrant-ribociclib combination demonstrated encouraging data in advanced, pre-treated ER+/HER2- breast cancer.
Opinion: I have a rare form of ALS. I have to fight my insurance company every six months for a game-changing drug
STAT
DECEMBER 13, 2024
When I was diagnosed at age 22 with ALS, a fatal disease without a cure, I knew I was going to have to fight for my life. I just didn’t know I would also have to fight against insurance companies denying me access to life-extending treatments. Amyotrophic lateral sclerosis, or ALS, takes your ability to walk, talk, eat, and eventually breathe.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ASH 2024: Expert Discusses Challenges, Future Research Opportunities With Bispecific Antibodies in Multiple Myeloma
Pharmacy Times
DECEMBER 13, 2024
Ira Zackon, MD, explains where future research lies regarding the implementation of bispecific antibodies in community oncology settings.
Opinion: Inclusive immigration policies protect America’s health care
STAT
DECEMBER 13, 2024
When I left Syria in 2014, I had a dream of becoming a U.S.-trained physician. I quickly realized that the American dream is real and that hard work truly pays off. I completed my master’s degree in international health policy and management, along with my clinical training in both internal and vascular medicine, at highly reputable institutions.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
My 72-Hour Fast
The Honest Apothecary
DECEMBER 13, 2024
Monday evening I was frustrated. Four weeks ago we had begun trying the carnivore diet. For me, it was an attempt to try something different to hopefully break out of a 6-month stall in my weight loss journey. Yes, that’s right. I began exercising and eating much better 1 year ago. Over the course of […] The post My 72-Hour Fast appeared first on The Honest Apothecary.
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety
Drug Topics
DECEMBER 13, 2024
A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.
STAT+: Up and down the ladder: The latest comings and goings
STAT
DECEMBER 13, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Q&A: Pharmacists’ Understanding of CKD Therapies, Adverse Effects | ASHP Midyear
Drug Topics
DECEMBER 13, 2024
Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success?
STAT
DECEMBER 13, 2024
CARLSBAD, Calif. — Stroll inside Ionis Pharmaceuticals’ Southern California headquarters, past the giant hanging glass sculpture of an RNA molecule, and you can’t miss it on the back wall: In bright red, a digital countdown clock ticks off the days, hours, minutes, and seconds until a moment the biotech is betting will be transformational.
Promising Therapies, Treatment Strategies for HR+ Breast Cancer | ASHP Midyear
Drug Topics
DECEMBER 13, 2024
A conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.
HHMI’s move to diversify funding sparks debate about ‘biomedical elite’
STAT
DECEMBER 13, 2024
One of the world’s largest funders of biomedical research is looking to spread the wealth around a little more evenly. The nonprofit Howard Hughes Medical Institute (HHMI) will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for a round of funds to be awarded in 2027. The goal is to “broaden institutional representation by encouraging applications from scientists in geographic regions where HHMI is not currently supporting scie
Q&A: Importance of Managing Comorbidities for Patients with MASLD | ASHP Midyear
Drug Topics
DECEMBER 13, 2024
Kathryn Litten, PharmD, discussed the pharmacists role in helping patients manage metabolic dysfunction-associated steatotic liver disease.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: South African regulator decides Vertex provides sufficient access to CF drugs, angering activists
STAT
DECEMBER 13, 2024
After a lengthy investigation, South African regulators decided Vertex Pharmaceuticals has sufficiently provided access to its cystic fibrosis medications, ending a high-profile episode that placed the company on the defensive over the cost of its treatments. But the move angered patient activists who argued the arrangement is inequitable and that some patients “will continue to suffer and die.
Deciphering the Role of CDK4/6 and PDL-1 in Breast Cancer Immunotherapy Strategies
Pharmacy Times
DECEMBER 13, 2024
Combining CDK4/6 and PDL-1 inhibitors enhances treatment responses in patients with hormone receptor positive and triple-negative breast cancer.
The conclusion(?) to the bird flu mystery and a Syrian doctor on coming to the U.S.
STAT
DECEMBER 13, 2024
Happy birthday to Taylor Swift! She’s now old enough to run for president of the United States (not saying she SHOULD, just that she COULD…) And happy birthday to my feature from one year ago about a little girl named Shelby , whose one-time gene therapy miracle cure took place over a grueling year. (Don’t miss the Taylor Swift name drop in the piece itself!
Approximately 1 in 6 US Adults With Asthma Report Non-Adherence to Medication Due to Cost
Pharmacy Times
DECEMBER 13, 2024
Despite the overall decline in medication non-adherence, adult patients with asthma are continuing to report taking less or skipping doses and refilling prescriptions later to save money.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Report: Tuberculosis R&D funding is up, but still short of goals and dominated by a few players
STAT
DECEMBER 13, 2024
Although research and development funding for tuberculosis reached new heights last year, the total fell substantially short of goals set by the United Nations and most of the increase came from just two organizations, according to a new report. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2 billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022.
Patients With PV Who Switched from Hydroxyurea to Ruxolitinib Had Improved Hematocrit, White Blood Cell Counts
Pharmacy Times
DECEMBER 13, 2024
Improvements were observed regardless of whether patients initiated ruxolitinib in the second or third line of treatment.
Where is AI winning in drug discovery? 4 use cases to know
Fierce Pharma
DECEMBER 13, 2024
Even though AI-designed drugs arent yet a household term for FDA-approved, commercially available therapies, they are a reality in clinical development pipelines. | Even though AI-designed drugs arent yet a household term for FDA-approved, commercially available therapies, they are a reality in clinical development pipelines.
FDA Grants Breakthrough Therapy Designation to Tobevibart With Elebsiran for Treatment of Chronic Hepatitis Delta
Pharmacy Times
DECEMBER 13, 2024
The treatments are currently undergoing evaluation in the SOLSTICE trial (NCT05461170).
FDA accepts Sobi North America’s thrombocytopenia therapy sNDA
Pharmaceutical Technology
DECEMBER 13, 2024
The US FDA has accepted Sobi North Americas avatrombopag (DOPTELET) sNDA to treat paediatric immune thrombocytopenia.
ASHP Midyear: Pharmacists Play Key Role in Addressing Depression in Women Through Medication Management
Pharmacy Times
DECEMBER 13, 2024
Pharmacists can make a significant impact by providing medication management, promoting nonpharmacologic approaches, supporting patients through life transitions.
Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance
Pharmafile
DECEMBER 13, 2024
13 December 2024 Amsterdam, the Netherlands CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased dealmaking on site. The events success is widely used as a proxy for overall growth in global pharma […] The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharmafile.
FDA Expands Indication for Impella Heart Pumps to Include Pediatric Patients
Pharmacy Times
DECEMBER 13, 2024
The pumps can now be used to treat pediatric patients who have symptomatic acute decompensated heart failure and cardiogenic shock.
Conduit and Sarborg link to optimise AI drug development
Pharmaceutical Technology
DECEMBER 13, 2024
Conduit has signed an agreement with Sarborg to leverage advanced artificial intelligence and cybernetics.
SABCS 2024: Unlocking the Potential of Breast Cancer Prevention Vaccines
Pharmacy Times
DECEMBER 13, 2024
Breast cancer prevention vaccines could have significant positive societal impact by reducing cancer diagnoses.
Roche wins Vabysmo prefilled syringe EU approval to intensify Eylea challenge
Pharmaceutical Technology
DECEMBER 13, 2024
Roches Vabysmo is now available in prefilled syringes and vials for three retinal conditions.
Tafasitamab With Lenalidomide Plus Rituximab Improves PFS in Patients With R/R FL
Pharmacy Times
DECEMBER 13, 2024
Compared with placebo, patients with relapsed/refractory (R/R) follicular lymphoma (FL) who were treated with tafasitamab showed a median progression-free survival (PFS) of 22.4 months.
Pharma Marketing Strategies: Unlocking Success in a Competitive Industry
Pharma Marketing Network
DECEMBER 13, 2024
Table of Contents Sr# Headings 1 Introduction 2 Understanding Pharma Marketing 3 Key Pharma Marketing Strategies 4 Embracing Digital Transformation 5 Building Trust with HCPs 6 Conclusion Introduction In the pharma industry, marketing isnt just about selling; its about creating value in an ultra-competitive space. With branded drugs dominating the market, strategies that blend innovation with empathy are essential.
Can dogs take pregabalin?
The Checkup by Singlecare
DECEMBER 13, 2024
Veterinarians use pregabalin in dogs to control seizures and manage chronic pain. It is not a first-choice drug for either condition but is added if first-line drug treatments dont work. Pregabalin is very similar to the drug gabapentin , which is also used for seizures and pain in dogs. Pregabalin is not approved for use in dogs, so its use in veterinary medicine is off-label.
Innovative Healthcare Advertising Strategies: Transforming Pharma Marketing in the Digital Era
Pharma Marketing Network
DECEMBER 13, 2024
Table of Contents Sr# Headings 1 Introduction 2 The Evolution of Healthcare Advertising 3 Top Healthcare Advertising Strategies 4 Harnessing Digital for Pharma Success 5 Conclusion Introduction Healthcare advertising has never been more dynamic, especially in the pharma world. With new trends emerging and regulations tightening, marketers must constantly innovate to capture attention and build trust.
Let's personalize your content